CLARITY News and Research

RSS

The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.

Tenofovir gel to prevent HIV transmission nearing approval

Anti HIV drug Tenofovir in its gel form is to be fast-tracked for approval by the US FDA. The announcement was made by Conrad, a nonprofit scientific organization based in Arlington, Virginia that works with reproductive health.

28 Oct 2010

New GlideScope Direct intubation trainer to facilitate instruction for classic direct laryngoscopy

Verathon Inc. is pleased to introduce the GlideScope Direct intubation trainer, designed to facilitate instruction of classic direct laryngoscopy.

28 Oct 2010

Two-thirds of fetuses with HLHS have strong chance of survival

When prenatal diagnosis detects the severe heart defect hypoplastic left heart syndrome (HLHS) in a fetus, a comprehensive prenatal evaluation is important to provide parents an accurate prognosis. In HLHS, one of the heart's pumping chambers is severely underdeveloped. However, say researchers, in two-thirds of cases, reconstructive surgery affords the infant an excellent chance of early survival.

27 Oct 2010

CHI releases new white paper on 510(k) review process

California Healthcare Institute today announced the release of a new white paper titled "Upcoming Changes to the 510(k) Process: New Approval Pathways and the Impact on Medical Device Development and Innovation." CHI is a non-profit public policy research and advocacy organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.

27 Oct 2010

New Australian start-up venture could lead to a revolution in personalized medicine

Pharmaceuticals that seek out cancerous cells and deliver treatments to them; imaging techniques that can help doctors detect diseases before the physical signs begin to appear; and medicines that are tailor-made for individual patients, are within the sights of an exciting new Australian start-up venture.

27 Oct 2010

La Jolla Institute scientist wins Malpighi Medal for pioneering work in heart disease

Klaus Ley, M.D, a scientist at the La Jolla Institute for Allergy & Immunology, was recently awarded the prestigious Malpighi Medal at the World Congress for Microcirculation in Paris, France. A lifetime achievement award presented by the European Society for Microcirculation, Dr. Ley received the honor in recognition of his pioneering endeavors in vascular immunology, a scientific discipline that he helped to pioneer, which looks at novel immune-based approaches to combating heart disease. He is only the 17th recipient of the biennial award worldwide.

26 Oct 2010

Dual antiplatelet therapy study expanded into Australia and New Zealand

The Harvard Clinical Research Institute (HCRI) announced today that the DAPT Study has expanded into Australia and New Zealand. Professor Ian Meredith, MBBS, Ph.D., interventional cardiologist at MonashHeart in Melbourne, Australia and National Coordinating Investigator for the DAPT Study in Australia, was the first Pacific Rim investigator to enroll patients into the study.

26 Oct 2010

Canon to showcase imageFORMULA document scanning portfolio at MGMA Annual Conference

Reflecting the increased need for medical practices and healthcare facilities to streamline patient record processes in order to increase efficiency across a range of insurance and billing functions, Canon U.S.A., Inc., a leader in digital imaging, will showcase an array of workflow simplifying solutions from its innovative imageFORMULA document scanning portfolio, including the new ScanFront 300P network scanner, at the Medical Group Management Association (MGMA) 2010 Annual Conference, October 24-27, 2010 at the Ernest N. Morial Convention Center in New Orleans.

25 Oct 2010

Aid agencies threaten to leave Afghanistan as President Karzai orders private security firms to dissolve

Companies and aid organizations implementing hundreds of millions of dollars in U.S.-funded projects here say they are preparing to leave Afghanistan unless President Hamid Karzai amends a decree that outlaws their private security protection, the Wall Street Journal reports.

25 Oct 2010

Arena's NDA receives Complete Response Letter for lorcaserin

Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese

25 Oct 2010

UHCMC improves workflow using Toshiba's suite of systems

One of the top priorities for healthcare facilities today is improving operational efficiency. To help address this issue, University Hospitals Case Medical Center (UHCMC) in Cleveland, Ohio, rated among the best hospitals in the nation, recently purchased a suite of systems from Toshiba America Medical Systems, Inc., including an Aplio MX, two Xario XGs and two Aplio XG systems.

21 Oct 2010

Endocrine Society's statement clarifies association between hormone therapy and breast cancer risk

Richard J. Santen, MD, lead author of The Endocrine Society's Scientific Statement on menopausal hormone therapy, can provide clarity on the association of hormone therapy and increased risk of breast cancer as reported in an article published this week in The Journal of the American Medical Association (JAMA)

21 Oct 2010

Cmed debuts Timaeus 5 unified eClinical platform and Timaeus HotSpot regulatory-compliant eClinical suite

Cmed Technology, an eClinical technology provider, today unveiled two product previews at two major pharmaceutical conferences. It debuted Timaeus 5, Cmed's newest version of its unified eClinical platform to manage data from Study Design through Reporting. Timaeus 5 adds enhanced usability, extended operational capabilities, streamlined investigator and monitor interaction, and expanded reporting capabilities.

18 Oct 2010

New insights into HIV infection process may allow antiviral drug development

New insights into the human immunodeficiency virus (HIV) infection process, which leads to acquired immunodeficiency syndrome (AIDS), may now be possible through a research method recently developed in part at the National Institute of Standards and Technology (NIST), where scientists have glimpsed an important protein molecule's behavior with unprecedented clarity.

15 Oct 2010

Role conflicts and high emotional demands increase risk of burnout in human service workers

For workers in human service settings, job factors like role conflicts and high emotional demands can increase the risk of burnout—leading to long-term sickness absence, reports a study in the September Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

12 Oct 2010

LC Luxuries announces acquisition of domain name CannaCare.com

LC LUXURIES LIMITED today announced that it has acquired the domain name CannaCare.com and will begin developing CannaCare.com as its nationwide physician marketing engine as it relates to the cannabis industry. Development is underway and the Company anticipates the site operational by the end of the year. Bonni Goldstein, MD, a board member for LC Luxuries Limited, will be materially involved with the content and direction of CannaCare.com.

4 Oct 2010

AcelRx completes ARX-02 End-of-Phase 2 meeting with FDA for cancer breakthrough pain management system

AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.

1 Oct 2010

Disparities in cardiac care begin when patients arrive at hospital emergency rooms: Study

The well-documented disparities in cardiac care may begin almost as soon as patients arrive at hospital emergency rooms. In a study published in Academic Emergency Medicine, Massachusetts General Hospital researchers report that African-American and Hispanic patients assessed for chest pain were less likely than white patients to be categorized as requiring immediate care, despite a lack of significant differences in symptoms.

27 Sep 2010

Health law affecting insurers, employers and comparative effectiveness research

Kaiser Health News has a list of eight provisions in the new health law that took effect this week as insurers, businesses and employers sort out what the new changes mean for them.

27 Sep 2010

First Edition: September 24, 2010

In today's news, more reports regarding the health reform provisions that took effect yesterday and more details on the GOP's "Pledge To America."

24 Sep 2010

CLARITY News and Research

Further Reading

Tenofovir gel to prevent HIV transmission nearing approval

New GlideScope Direct intubation trainer to facilitate instruction for classic direct laryngoscopy

Two-thirds of fetuses with HLHS have strong chance of survival

CHI releases new white paper on 510(k) review process

New Australian start-up venture could lead to a revolution in personalized medicine

La Jolla Institute scientist wins Malpighi Medal for pioneering work in heart disease

Dual antiplatelet therapy study expanded into Australia and New Zealand

Canon to showcase imageFORMULA document scanning portfolio at MGMA Annual Conference

Aid agencies threaten to leave Afghanistan as President Karzai orders private security firms to dissolve

Arena's NDA receives Complete Response Letter for lorcaserin

UHCMC improves workflow using Toshiba's suite of systems

Endocrine Society's statement clarifies association between hormone therapy and breast cancer risk

Cmed debuts Timaeus 5 unified eClinical platform and Timaeus HotSpot regulatory-compliant eClinical suite

New insights into HIV infection process may allow antiviral drug development

Role conflicts and high emotional demands increase risk of burnout in human service workers

LC Luxuries announces acquisition of domain name CannaCare.com

AcelRx completes ARX-02 End-of-Phase 2 meeting with FDA for cancer breakthrough pain management system

Disparities in cardiac care begin when patients arrive at hospital emergency rooms: Study

Health law affecting insurers, employers and comparative effectiveness research

First Edition: September 24, 2010

Latest eBooks

New horizons in drug discovery: High-throughput & target-to-therapy advances

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology